E Rødevand

1.4k citations

29 papers · 1.0k indexed · h-index 14

Impact in

Rheumatology top 1%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 5%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Rheumatology 21
- Rheumatoid Arthritis Research and Therapies 18
- Spondyloarthritis Studies and Treatments 14
- Systemic Lupus Erythematosus Research 3
Hematology 8
- Autoimmune and Inflammatory Disorders Research 8

Co-authors: K. Mikkelsen (12 shared papers)C. Kaufmann (11 shared papers)Tore K Kvien (9 shared papers)E. Lie (10 shared papers)Wenche Koldingsnes (5 shared papers)Martina Kron (2 shared papers)S. Kary (2 shared papers)H. Küpper (2 shared papers)
Journals: Annals of the Rheumatic Diseases (14 papers)Scandinavian Journal of Rheumatology (4 papers)Lara D. Veeken (3 papers)Data Archiving and Networked Services (DANS) (2 papers)PubMed (6 papers)
Partner nations: Norway Netherlands United Kingdom

In The Last Decade

E Rødevand

25 papers receiving 1.0k citations

Peers

Countries citing papers authored by E Rødevand

Since Specialization

Citations

This map shows the geographic impact of E Rødevand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Rødevand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Rødevand more than expected).

Fields of papers citing papers by E Rødevand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Rødevand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Rødevand. The network helps show where E Rødevand may publish in the future.

Co-authors

The 25 scholars most cited alongside E Rødevand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E Rødevand Line = papers co-authored together E Rødevand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study Annals of the Rheumatic Diseases ·Martín Rudwaleit, E Rødevand, Peter Holck, J. Vanhoof, Martina Kron, S. Kary, H. Küpper	2008	208
2	The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study Annals of the Rheumatic Diseases ·K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde, Marte Schrumpf Heiberg, Åse Stavland Lexberg, E Rødevand, S. Kalstad, K. Mikkelsen, Tore K Kvien	2013	131
3	A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. PubMed ·Tore K Kvien, Heiberg, E. Lie, C. Kaufmann, K. Mikkelsen, Bjørn Yngvar Nordvåg, E Rødevand	2006	109
4	Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register Annals of the Rheumatic Diseases ·E. Lie, Désirée van der Heijde, Till Uhlig, K. Mikkelsen, E Rødevand, Wenche Koldingsnes, C. Kaufmann, Tore K Kvien	2010	108
5	Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions Annals of the Rheumatic Diseases ·Filip Van den Bosch, Bernhard Manger, Philippe Goupille, Neil McHugh, E Rødevand, Peter Holck, Ronald van Vollenhoven, Marjatta Leirisalo‐Repo, Oliver FitzGerald, Martina Kron, Michael Frank, S. Kary, H. Küpper	2009	100
6	Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis Annals of the Rheumatic Diseases ·E. Lie, D. van der Heijde, T. Uhlig, Marte Schrumpf Heiberg, Wenche Koldingsnes, E Rødevand, C. Kaufmann, K. Mikkelsen, T.K. Kvien	2009	88
7	Work disability and health-related quality of life in males and females with psoriatic arthritis Annals of the Rheumatic Diseases ·Marianne Wallenius, Johan F. Skomsvoll, Wenche Koldingsnes, E Rødevand, K. Mikkelsen, C. Kaufmann, T.K. Kvien	2008	72
8	The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study Annals of the Rheumatic Diseases ·Marte Schrumpf Heiberg, C. Kaufmann, E Rødevand, K. Mikkelsen, Wenche Koldingsnes, Petter Mowinckel, Tore K Kvien	2007	59
9	Comparison of work disability and health‐related quality of life between males and females with rheumatoid arthritis below the age of 45 years Scandinavian Journal of Rheumatology ·Marianne Wallenius, Johan F. Skomsvoll, Wenche Koldingsnes, E Rødevand, K. Mikkelsen, C. Kaufmann, Tore K Kvien	2008	32
10	Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria Lara D. Veeken ·K. M. Fagerli, E. Lie, Désirée van der Heijde, Marte Schrumpf Heiberg, C. Kaufmann, E Rødevand, Kim Lyngby Mikkelsen, S. Kalstad, T. K. Kvien	2012	31
11	A novel mutation in theNOD2gene associated with Blau syndrome: a Norwegian family with four affected members Scandinavian Journal of Rheumatology ·Nils Milman, K. Ursin, E Rødevand, Finn Cilius Nielsen, Thomas van Overeem Hansen	2009	28
12	Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register Annals of the Rheumatic Diseases ·E. Lie, D. van der Heijde, Till Uhlig, Kim Lyngby Mikkelsen, S. Kalstad, C. Kaufmann, E Rødevand, T.K. Kvien	2011	19
13	Contemporary use of disease‐modifying drugs in the management of patients with early rheumatoid arthritis in Norway Scandinavian Journal of Rheumatology ·Cathrin Nikolaisen, Tore K Kvien, K. Mikkelsen, C. Kaufmann, E Rødevand, Johannes C. Nossent	2009	15
14	Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA Lara D. Veeken ·E. Lie, Till Uhlig, D. van der Heijde, E Rødevand, S. Kalstad, C. Kaufmann, Kim Lyngby Mikkelsen, T. K. Kvien	2011	14
15	Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study Lara D. Veeken ·K. M. Fagerli, D. van der Heijde, Marte Schrumpf Heiberg, Ada Wierød, S. Kalstad, E Rødevand, K. Mikkelsen, T.K. Kvien, Lie E	2014	10
16	Predictors of ASDAS Major Improvement in Patients with Ankylosing Spondylitis Receiving Their First TNF Inhibitor. Results From a Longitudinal Observational Study Data Archiving and Networked Services (DANS) ·K. M. Fagerli, E. Lie, Heiberg, Désirée van der Heijde, S. Kalstad, K. Mikkelsen, C. Kaufmann, E Rødevand, T.K. Kvien	2011	4
17	Aiming for Remission in Rheumatoid Arthritis : Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen Data Archiving and Networked Services (DANS) ·Espen A. Haavardsholm, Anna‐Birgitte Aga, Inge Christoffer Olsen, H.B. Hammer, Till Uhlig, Hallvard Fremstad, T. M. Madland, Åse Stavland Lexberg, Hilde Haukeland, E Rødevand, Christian Høili, Hilde Stray, Anne Noraas Bendvold, Inger Johanne Widding Hansen, Gunnstein Bakland, Lena Bugge Nordberg, Siri Lillegraven, D. van der Heijde, Tore K Kvien	2015	4
18	[Arthritis after BCG treatment of bladder cancer. A rare complication]. PubMed ·E Rødevand, Arild Faxvaag, Monika Østensen, Bjørn Brevik	1996	3
19	AB0441 Drug survival and reason for drop-out in rheumatoid arthritis patients with a non-medical switch from originator to biosimilar etanercept – preliminary data from a norwegian multicenter study Annals of the Rheumatic Diseases ·Glenn Haugeberg, G. Bakland, E Rødevand, Bjørg‐Tilde Svanes Fevang, Inger Johanne Widding Hansen, Andreas P. Diamantopoulos	2018	3
20	[Takayasu's arteritis]. PubMed ·E Rødevand, Skomsvoll Jf, Marianne Wallenius, Henriksen Az, Terje Skjærpe, Tafjord Ab	2001	2

About E Rødevand

E Rødevand is a scholar working on Rheumatology, Hematology, Immunology, Nephrology and Biochemistry, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (14 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Systemic Lupus Erythematosus Research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers) and Vasculitis and related conditions (2 papers). The work is most often cited by research in Rheumatology (852 citations), Hematology (340 citations), Immunology (468 citations), Ophthalmology (142 citations) and Dermatology (52 citations). E Rødevand has collaborated with scholars based in Norway, Netherlands and United Kingdom. Frequent co-authors include K. Mikkelsen, C. Kaufmann, Tore K Kvien, E. Lie, Wenche Koldingsnes, Martina Kron, S. Kary, H. Küpper, Peter Holck and Marte Schrumpf Heiberg. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, Lara D. Veeken, Data Archiving and Networked Services (DANS) and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact